Form 4: NRC Executive Exercises Options, Sells Shares for Tax

Sentiment:

Insider Transaction Report


Helen Hrdy, EVP & COO of National Research Corp, exercised stock options and subsequently sold a portion of the shares for tax purposes.

Summary

  • Helen Hrdy, Executive Vice President & Chief Operating Officer of National Research Corp (NRC), engaged in transactions involving the company's common stock.
  • On December 15, 2025, Hrdy exercised employee stock options to acquire 12,346 shares of common stock at an exercise price of $15.23 per share.
  • Concurrently, Hrdy disposed of 11,244 shares of common stock at a price of $17.64 per share, likely to cover tax obligations associated with the option exercise.
  • Following these transactions, Hrdy beneficially owns 140,518 shares of National Research Corp common stock directly.
  • The exercised options had an exercisable date of January 5, 2021, and an expiration date of January 5, 2026.

Sentiment

Score: 6

Explanation: The exercise of options is generally positive as it indicates an insider realizing value from their compensation, often implying a belief in the stock's value. However, the subsequent sale, even for tax purposes, slightly offsets this by reducing the insider's direct holdings. It's a routine compensation event.

Positives

  • The exercise of stock options by a key executive indicates a realization of value and potential confidence in the company's stock performance, as the exercise price ($15.23) is below the market price at the time of disposition ($17.64).
  • The executive continues to hold a significant number of shares (140,518) after the transactions, maintaining a vested interest in the company's future.

Negatives

  • The disposition of 11,244 shares, even if for tax purposes, reduces the executive's direct beneficial ownership in the company.

Future Outlook

NA

Industry Context

This is a routine insider transaction filing (Form 4) and does not provide broader industry context or trends. It reflects an executive's compensation-related activity within the healthcare information technology or research services sector where National Research Corp operates.

Stakeholder Impact

  • Shareholders: The transaction provides transparency into executive compensation and ownership, showing an executive realizing value from options while maintaining a significant stake. This is a routine event and typically has minimal direct impact on share price or shareholder value.

Key Dates

DateDescription
01/05/2021Employee Stock Option exercisable date
12/15/2025Date of stock option exercise and subsequent share disposition
12/17/2025Date the Form 4 was signed by attorney-in-fact
01/05/2026Employee Stock Option expiration date

Keywords

National Research Corp, NRC, Insider Transaction, Form 4, Stock Options, Executive Compensation, Share Sale, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.